Phacorefractive surgery in patients with high myopia

Authors

Abstract

Introduction: myopia is an ametropia with a high prevalence index that causes a decrease in visual acuity. Phacorefractive surgery, or removal of the clear lens and its replacement by an intraocular lens, represents a therapeutic option for this condition.Objective: to characterize from the demographic, clinical and surgical point of view those operated on for high myopia by means of phaco-refractive surgery.

Methods: a prospective descriptive observational study was carried out on all patients of 40 years or more (34 patients, 66 eyes) with high myopia who attended the Ophthalmological Center of the Ciego de Ávila province between January 2011 and October 2017. Ethical precepts were followed.

Results: the female sex predominated (61,76 %) and the age group from 40 to 44 years (70,59 %). Most of the patients (86,36 %) improved visual acuity without correction in the postoperative period. In almost all the operated eyes (92,42 %), endothelial cell loss occurred. Sphere and cylinder values were reduced, and astigmatism was not induced. Only 10,52 % of the operated eyes were complicated: in the perioperative the complication was ocular hypertension (3,52 %); in the postoperative period the acute anterior uveitis (2,52 %) and in the late postoperative period, the opacity of the posterior capsule (5,52 %).

Conclusions: young adults and women predominated. Phacorefractive surgery, although not without risks, constituted a safe and corrective therapeutic guarantee in patients with high myopia.

Downloads

Download data is not yet available.

Author Biography

Lisset Aragón Cañizares

Centro Oftalmológico

Downloads

Published

2020-01-31

How to Cite

1.
Aragón Cañizares L, Santos Pérez FA, Mayea Díaz DY, Zayas Ribalta Y. Phacorefractive surgery in patients with high myopia. Mediciego [Internet]. 2020 Jan. 31 [cited 2026 Feb. 4];26(1):e1516. Available from: https://revmediciego.sld.cu/index.php/mediciego/article/view/1516

Issue

Vol. 26 No. 1 (2020)

Section

Original article

License

Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):

You are free to:

  • Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  • Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

The journal is not responsible for the opinions and concepts expressed in the works, which are the exclusive responsibility of the authors. The Editor, with the assistance of the Editorial Committee, reserves the right to suggest or request advisable or necessary modifications. Original scientific works are accepted for publication, as are the results of research of interest that have not been published or sent to another journal for the same purpose.

The mention of trademarks of specific equipment, instruments or materials is for identification purposes, and there is no promotional commitment in relation to them, neither by the authors nor by the editor.